Pages that link to "Q35028313"

The following pages link to A Klothoβ Variant Mediates Protein Stability and Associates With Colon Transit in Irritable Bowel Syndrome With Diarrhea (Q35028313):

Displaying 41 items.

• Endocrine fibroblast growth factors 15/19 and 21: from feast to famine (Q24629260) (← links)
• Irritable Bowel Syndrome: Methods, Mechanisms, and Pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome (Q26860280) (← links)
• Brain-gut axis: from basic understanding to treatment of IBS and related disorders (Q27024801) (← links)
• Bile Acid diarrhea: prevalence, pathogenesis, and therapy (Q28086845) (← links)
• Elobixibat and its potential role in chronic idiopathic constipation (Q28244603) (← links)
• Review article: bile acid diarrhoea - pathogenesis, diagnosis and management (Q28273649) (← links)
• Bile acid malabsorption in chronic diarrhea: pathophysiology and treatment (Q33459719) (← links)
• RNA sequencing shows transcriptomic changes in rectosigmoid mucosa in patients with irritable bowel syndrome-diarrhea: a pilot case-control study (Q33764582) (← links)
• Genetic variation in GPBAR1 predisposes to quantitative changes in colonic transit and bile acid excretion (Q34131127) (← links)
• Fibroblast growth factor 19 in patients with bile acid diarrhoea: a prospective comparison of FGF19 serum assay and SeHCAT retention (Q34366988) (← links)
• Advances in understanding of bile acid diarrhea (Q34412381) (← links)
• Therapeutic targeting of bile acids (Q35958534) (← links)
• Review article: biomarkers and personalised therapy in functional lower gastrointestinal disorders (Q36021269) (← links)
• Genetics of irritable bowel syndrome. (Q36577043) (← links)
• Bowel functions, fecal unconjugated primary and secondary bile acids, and colonic transit in patients with irritable bowel syndrome (Q37185328) (← links)
• Pharmacogenetics of the effects of colesevelam on colonic transit in irritable bowel syndrome with diarrhea (Q37259375) (← links)
• Irritable bowel syndrome-diarrhea: characterization of genotype by exome sequencing, and phenotypes of bile acid synthesis and colonic transit (Q37575689) (← links)
• Irritable bowel syndrome: emerging paradigm in pathophysiology (Q37629670) (← links)
• New insights into bile acid malabsorption. (Q37909078) (← links)
• The role of pharmacogenetics in nonmalignant gastrointestinal diseases (Q37981892) (← links)
• Genes and functional GI disorders: from casual to causal relationship. (Q38119270) (← links)
• Bile acid diarrhoea and FGF19: new views on diagnosis, pathogenesis and therapy (Q38198859) (← links)
• The role of bile acids in functional GI disorders. (Q38217671) (← links)
• Pharmacogenetics and the treatment of functional gastrointestinal disorders (Q38661352) (← links)
• Increased colonic bile acid exposure: a relevant factor for symptoms and treatment in IBS. (Q39208620) (← links)
• Pathophysiology of irritable bowel syndrome (Q39238569) (← links)
• Fibroblast Growth Factor 19 and 7α-Hydroxy-4-Cholesten-3-one in the Diagnosis of Patients With Possible Bile Acid Diarrhea. (Q42263341) (← links)
• Increased bile acid biosynthesis is associated with irritable bowel syndrome with diarrhea (Q43183646) (← links)
• Irritable Bowel Syndrome: Pathophysiology and Current Therapeutic Approaches (Q48389586) (← links)
• Nuclear receptor regulation of bile acid and nutrient metabolism: 51st Annual Max Miller Lecture in Diabetes Research presented by David Mangelsdorf, PhD. (Q48532540) (← links)
• Characterizing Factors Associated With Differences in FGF19 Blood Levels and Synthesis in Patients With Primary Bile Acid Diarrhea. (Q50535134) (← links)
• Dissecting Molecular Mechanisms in Bile Acid Diarrhea (Q51286764) (← links)
• Effect of increased bile acid synthesis or fecal excretion in irritable bowel syndrome-diarrhea. (Q51318198) (← links)
• Pharmacogenetics in irritable bowel syndrome. (Q53638382) (← links)
• Association of genes involved in bile acid synthesis with the progression of primary biliary cirrhosis in Japanese patients. (Q54274187) (← links)
• Irritable bowel syndrome (Q56965677) (← links)
• Pros and Cons of the SeHCAT Test in Bile Acid Diarrhea: A More Appropriate Use of an Old Nuclear Medicine Technique (Q60625155) (← links)
• Personalized medicine in functional gastrointestinal disorders: Understanding pathogenesis to increase diagnostic and treatment efficacy (Q64096479) (← links)
• Bile Acid Diarrhea and NAFLD: Shared Pathways for Distinct Phenotypes (Q91657985) (← links)
• A Clostridia-rich microbiota enhances bile acid excretion in diarrhea-predominant irritable bowel syndrome (Q91798949) (← links)
• Irritable Bowel Syndrome between Molecular Approach and Clinical Expertise-Searching for Gap Fillers in the Oxidative Stress Way of Thinking (Q92814756) (← links)